Wertpapierdatensatz · archiviertes Quartal
ABSI
Absci Corporation · Healthcare · Biotechnology
15Erfasste Halter
-1Δ Inhaber
60.11MGehaltene Aktien
$182.75MGemeldeter Wert
+1Neue Positionen
−2Ausstiege
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -6.2% ·
Aktienfluss +16.1% ·
neue Nettopositionen -6.7%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 82 | +7 | 112.04M | $1.30B | +11 | −4 |
| Q1 2026 | 77 | +13 | 90.86M | $272.61M | +16 | −3 |
| Q4 2025 | 64 | 0 | 89.20M | $311.30M | — | — |
| Q3 2025 | 15 | -1 | 60.11M | $182.75M | +1 | −2 |
| Q2 2025 | 13 | 0 | 50.18M | $128.95M | +2 | −2 |
| Q1 2025 | 10 | 0 | 17.56M | $44.09M | +1 | −1 |
| Q4 2024 | 10 | 0 | 15.09M | $39.55M | +1 | −1 |
| Q3 2024 | 9 | 0 | 11.86M | $45.29M | +1 | −1 |
| Q2 2024 | 9 | — | 12.14M | $37.33M | — | — |
Wer es hält · Q3 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 22.08M | +15.4% | $67.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 22.08M | +15.4% | $67.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 22.08M | +15.4% | $67.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | ARK Investment Management ✦ | 12.16M | +21.1% | $36.97M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 5 | BlackRock ✦ (passiv) | 10.58M | +26.6% | $32.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 10.58M | +26.6% | $32.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 10.58M | +26.6% | $32.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 10.58M | +26.6% | $32.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 10.58M | +26.6% | $32.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 10.58M | +26.6% | $32.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 10.58M | +26.6% | $32.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 10.58M | +26.6% | $32.17M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passiv) | 7.28M | +12.9% | $22.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passiv) | 7.28M | +12.9% | $22.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passiv) | 7.28M | +12.9% | $22.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Geode Capital Management ✦ (passiv) | 3.05M | +24.8% | $9.28M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passiv) | 3.05M | +24.8% | $9.28M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (passiv) | 2.06M | +14.5% | $6.28M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 969.87K | — | $2.95M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 969.87K | — | $2.95M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 969.87K | — | $2.95M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 969.87K | — | $2.95M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 969.87K | — | $2.95M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 969.87K | — | $2.95M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 969.87K | — | $2.95M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Millennium Management ✦ | 508.92K | +121.3% | $1.55M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | Wellington Management ✦ | 377.86K | -0.1% | $1.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 28 | Wellington Management ✦ | 377.86K | -0.1% | $1.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | Wellington Management ✦ | 377.86K | -0.1% | $1.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 343.00K | — | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 343.00K | — | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 343.00K | — | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 343.00K | — | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 343.00K | — | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 343.00K | — | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 343.00K | — | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 343.00K | — | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 343.00K | — | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 343.00K | — | $1.04M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Goldman Sachs Group ✦ | 286.30K | — | $870,346 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Goldman Sachs Group ✦ | 286.30K | — | $870,346 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Citadel Advisors ✦ | 165.09K | Neu | $501,877 | 0.0% | New | 1 | SEC ↗ |
| 43 | Citadel Advisors ✦ | 165.09K | Neu | $501,877 | 0.0% | New | 1 | SEC ↗ |
| 44 | Two Sigma Investments ✦ | 127.16K | -78.1% | $386,551 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 45 | T. Rowe Price ✦ | 70.57K | +29.0% | $215,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 35.36K | -41.7% | $107,497 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 35.36K | -41.7% | $107,497 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 35.36K | -41.7% | $107,497 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 35.36K | -41.7% | $107,497 | 0.0% | ▼ Trim | 5 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Citadel Advisors | $501,877 | 0.0% |
| Citadel Advisors | $501,877 | 0.0% |
Ausgestiegen
| Marshall Wace | $1.58M | war 0.0% |
| D. E. Shaw & Co. | $46,024 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 159 Inhaber, 118.34M Anteile, $354.64M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q3 2025 ·
Methodik ·
Über die API abrufen